GlassScriptPhysician profile
Cynthia A Brown
NPI 1700035151
$2,929.78
in general payments reported to CMS, 2019-2025
16 companies · $411 in 2025
The $411 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $297 · 2022: $768 · 2023: $631 · 2024: $822 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,823 · Education: $41.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,822.95 |
| Education | $41.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $493.11 | 2022-2024 | Krystexxa |
| Abbott Laboratories | $405.15 | 2022-2025 | Freestyle Libre 3, Freestyle Libre, Freestyle Libre 2 |
| Abbvie INC. | $346.40 | 2021-2023 | |
| Incyte Corporation | $342.04 | 2021-2024 | Jakafi |
| Astrazeneca Pharmaceuticals LP | $338.43 | 2024-2025 | Airsupra, Breztri |
| Teva Pharmaceuticals USA, INC. | $207.57 | 2023-2024 | Austedo Xr |
| Paratek Pharmaceuticals, INC. | $157.84 | 2023-2024 | Nuzyra |
| Evoke Pharma, INC. | $154.14 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $97.21 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.08 | 2024-2025 | Lifevest |
| Esperion Therapeutics, INC. | $74.98 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $71.96 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.53 | 2023 | Jardiance |
| Sanofi-Aventis U.S. LLC | $41.99 | 2024 | |
| Medtronic, INC. | $20.88 | 2023 | Corevalve Evolut R |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $14.47 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.